Upstream Bio Inc (UPB): Narx-foyda va o‘sish multiplikatori
Barqaror geosiyosiy fon va sanksiyalarning yo'qligi Upstream Bio Inc (UPB) rivojlanishini qo'llab-quvvatlaydi. PEG koeffitsiyenti qiymat dinamikasini namoyish etadi, bunda 0.00 qiymati metrika darajasini ifodalaydi. Biznes iqtisodiy sikllardan mustaqil bo'lsa-da, ventura kapitaliga nisbatan sezgirligini saqlab qolmoqda. Noyob antitelolarning yaratilishi minimal ishlab chiqarish xarajatlari bilan global qamrov va yuqori masshtablanishni ta'minlaydi.
Upstream Bio Inc (UPB) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Upstream Bio Inc|UPB - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati upstreambio.com|UPB - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Upstream Bio Corp|UPB - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli majburiyatlar Upstream Bio|Oraliq qoplama koeffitsiyenti upstreambio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
UPB - Sof daromad|Kelajakdagi sof foyda Upstream Bio Inc|UPB - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori Upstream Pharma|UPB - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Upstream Bio Corp|UPB - EBITDA operatsion foydasi|Bir aksiya uchun sof foyda (EPS TTM) Upstream Bio|UPB - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi upstreambio.com|UPB - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Upstream Bio Inc
Kompaniyaning jamlanma tahliliyoti:UPB Upstream Bio, Inc.
PEG koeffitsiyenti aktivning bozor qiymatini uning foyda o'sish sur'ati bilan solishtiradi, bunda birdan past qiymat biznesning kengayishiga nisbatan qadrsizlanganligini anglatadi. Innovatsion biologik preparatlarni ishlab chiqayotgan Upstream Bio Inc (UPB) uchun PEG koeffitsiyenti orqali qadrsizlanganlik tahlili klinik ishlab chiqish bosqichining investitsiya jozibadorligini baholash imkonini beradi va joriy aksiya narxining fundamental adolatli ekanligini aniqlaydi.
Upstream Bio Inc raqobatchilari
O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati argenx N.V.|Narxning foydaga va o‘sish sur’atiga nisbati BioNTech Group BNTX|ABVX - Narx-foyda va o‘sish multiplikatori|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|IMVT (Immunovant) - Narx-foyda va o‘sish multiplikatori|Kiniksa Pharmaceuticals, Ltd. (KNSA) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Grifols Group|O‘sishni hisobga olgan narx-foyda koeffitsiyenti ADPT (Adaptive Biotechnologies Inc.)|PEG multiplikatori CLDX|AUPH - O‘sish sur’atiga tuzatilgan narx-foyda|BioCryst Pharmaceuticals - Narx-foyda va o‘sish multiplikatori|PEG multiplikatori Vera Therapeutics Inc VERA|DNTH - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati PHVS|abcellera.com (ABCL) - Narxning foydaga va o‘sish sur’atiga nisbati|TRML - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narx-foyda va o‘sish multiplikatori PGEN|PHAR (Pharming Group NV) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|ZBIO (Zenas Corp) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori IMNM (Immunome, Inc.)|gossamerbio.com (GOSS) - O‘sish sur’atiga tuzatilgan narx-foyda|KalVista Pharmaceuticals, Inc. - PEG multiplikatori|SEPN - PEG multiplikatori|Pieris Pharmaceuticals Inc (PVLA) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Savara Pharma|Narx-foyda va o‘sish multiplikatori RIGL|ANAB: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ATXS|Narxning foydaga va o‘sish sur’atiga nisbati ENGN (enGene Holdings Inc)|PEG multiplikatori RAPT (RAPT Therapeutics, Inc.)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Aerovate Therapeutics, Inc. (JBIO)|ACRS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atiga tuzatilgan narx-foyda kyvernatx.com|TLSA (Tiziana Life Sciences Ltd) - Narx-foyda va o‘sish multiplikatori|Cabaletta Bio Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|VTYX (Ventyx Bio) - PEG multiplikatori|Theratechnologies, Inc (THTX) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati Avalo Therapeutics, Inc (AVTX)|eledon.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori AGEN (Agenus Inc.)|CLYM - Narx-foyda va o‘sish multiplikatori|ZURA: Narx-foyda va o‘sish multiplikatori|ATYR - PEG multiplikatori|adagene.com (ADAG) - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati IMA (Ikena Oncology)|STTK (Shattuck Labs Inc) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati EQ|Narxning foydaga va o‘sish sur’atiga nisbati Connect Biopharma (CNTB)|IMUX: Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|PEG multiplikatori ATRA (Atara Bio)|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti IFRX|X4 Pharmaceuticals, Inc. - PEG multiplikatori|ACET - PEG multiplikatori|celularity.com (CELU) - Narxning foydaga va o‘sish sur’atiga nisbati|INmune Bio Corporation - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati Barinthus Biotherapeutics|Narx-foyda va o‘sish multiplikatori kezarlifesciences.com (KZR)|PEG multiplikatori SABS|PEG multiplikatori Akari Therapeutics PLC (AKTX)|Enlivex Therapeutics Ltd. - Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti QTTB|GeoVax Labs, Inc. - PEG multiplikatori|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati edesabiotech.com EDSA|iBio (IBIO) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Carisma Therapeutics Inc.|Narxning foydaga va o‘sish sur’atiga nisbati XTL Biopharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori Bolt Bio (BOLT)|Narx-foyda va o‘sish multiplikatori HCWB (HCW Biologics Inc.)|PEG multiplikatori aptevotherapeutics.com (APVO)|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX: O‘sishni hisobga olgan narx-foyda koeffitsiyenti|GRI Bio Corp - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda XORTX Corp|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com (REVB) - PEG multiplikatori|Narxning foydaga va o‘sish sur’atiga nisbati Indaptus Therapeutics, Inc.|Scinai Immunotherapeutics Ltd - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati affimed.com|Allakos - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati HOOK (HOOKIPA Pharma, Inc.)|IGMS - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ITOS (iTeos Therapeutics Inc)|OCEA: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda TC BioPharm Ltd (TCBP)|THRD (Third Harmonic Bio) - PEG multiplikatori
